Moles and melanomas - Who's at risk, who knows, and who cares? A strategy to inform those at high risk

British Journal of General Practice

Volumn 49, Issue 440, 1999, Pages 199-203

  Jackson, Arthur ^b   Wilkinson, Clare ^a   Pill, Roisin ^b  

^a UWCM Academic Unit   (United Kingdom)

^b NONE

Author keywords

Malignant melanoma; Patient awareness; Skin cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AWARENESS; FEMALE; GENERAL PRACTICE; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; LIFESTYLE; MALE; MELANOMA; NEVUS; NORMAL HUMAN; PATIENT INFORMATION; PRIMARY PREVENTION; QUESTIONNAIRE; RISK FACTOR; SECONDARY PREVENTION; SELF REPORT; SKIN CANCER; SOCIAL CLASS; SUN EXPOSURE; SUNBURN;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; ENGLAND; FAMILY PRACTICE; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 0032985566     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. MacKie RM, Hole D, Hunter JAA, et al. Cutaneous malignant melanoma in Scotland: incidence, survival and mortality, 1979-1994. BMJ 1997; 315: 1117-1121.
2. Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality. [IARC Scientific Publication No 121.] Lyons, France: International Agency for Research on Cancer, 1993.
3. The Cancer Research Campaign Factsheets. Factsheet 4.1 : Malignant Melanoma. UK: CRC, 1995.
4. Higgins E, Du Vivier A, Malignant melanoma - a review: early diagnosis is the key. Br J Clin Pract 1991; 45(2): 109-115.
5. Lowitt MH, Lowitt NR. Recent advances in dermatology. Prognostic factors in malignant melanoma. BMJ 1995; 311: 1616-1617.
6. Doherty VR, MacKie RM. Reasons for poor prognosis in British patients with cutaneous malignant melanoma. BMJ 1986; 292: 987-990.
7. Dunkley MP, Morris AM. Cutaneous malignant melanoma: audit of the diagnosis process. Am R Coll Surg Eng 1991; 73(4): 248-252.
8. Hennrikus D, Girges A, Redman S, Sanson-Fisher RW. A community study of delay in presenting with signs of a melanoma to medical practitioners. Arch Dermatol 1991; 127(3): 356-361.
9. Kringe JE, Isaacs S, Hudson DA, et al. Delay in the diagnosis of cutaneous melanoma. A prospective study in 250 patients. Cancer 1991; 68(9): 2064-2068.
10. Hill D, White V, Mark R, Borland R. Changes in sun-related attitudes and behaviours, and reduced prevalence in the population at high risk of melanoma. Eur J Cancer Prevention 1993; 2(6): 447-456.
11. Bourke JF, Healsmith MF, Graham-Brown RA. Melanoma awareness and sun exposure in Leicester. Br J Dermatology 1995; 132: 251-256.
12. D'Arcy C, Holman J, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. JNCI 1986; 76(3): 403-415.
13. Cody R, Lee C. Behaviours, beliefs and intentions in skin cancer prevention. J Behav Med 1990; 13(4): 373-389.
14. Hughes B, Altman D, Newton J. Melanoma and skin cancer: evaluation of a health education programme for secondary schools. Br J Dermatol 1993; 128:412-417.
15. Carmel S, Shani E, Rosenberg L. The role of age and an expanded health belief model in predicting skin cancer protective behaviour. Health Ed Res 1994: 9(4): 433-447.
16. Arthey S. Clarke V. Sun tanning and sun protection: a review of the psychology literature. Soc Sci Med 1995; 40(2): 265-274.
17. Jackson A, Wilkinson C, Ranger M. et al. Can primary prevention and selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a sell administered risk score. BMJ 1998; 316: 34 39.
18. MacKie RM, Freudenberger T, Aitchinson TC. Personal risk factor chart for cutaneous malignant melanoma. Lancet 1989; 26: 487-490.
19. Borland R, Marks R, Noy S. Public knowledge about characteristics of moles and melanomas. Aust J Pub Health 1992; 16(4): 370-375.
20. MacKie RM. Clinical recognition of early invasive malignant melanoma. BMJ 1990; 301: 1005-1006.
21. Keesling B. Friedman HS. Psychological factors in sunbathing and sunscreen use. Health Psychol 1987; 6: 477-493.
22. Fiala B, Kopp M, Gunther V. Why do young women use sunbeds? A comparative psychological study. Br J Dermatol 1997; 137: 950-954.
23. Green A, Siskind V, Bain C, Alexander J. Sunburn and malignant melanoma. Br J Cancer 1985; 51(3): 393-397.
24. Armstrong BK, Kricker A. Skin cancer review. Dermatol Clinics 1995; 13(3): 583-594.
25. Osterland A, Tucker MA, Stone BJ, Jensen OM. The Danish casecontrol study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer 1988; 42(3): 319-324.
26. Diffey BL. Tanning with ultraviolet sun beds. BMJ 1990; 301: 773-774.
27. Swerdlow AJ, English JS, MacKie RM, et al. Fluorescent lights, ultraviolet lamps and risk of cutaneous melanoma. BMJ 1998: 297: 1172.
28. Walter SD, Marrett LD, From L, et al. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 1990; 131(2): 232-243.
29. Westerdal J, Olsson H, Masback A, et al. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol 1994; 140(8): 691-699.
30. Holland J. Screening: reasons to be cautious. BMJ 1993; 306: 1222-1223.
31. Morris J. Screening for malignant melanoma. J Med Screening 1994; 1(1): 2.
32. Fallowfield L. Psychological intervention in cancer. BMJ 1995; 311: 1316-1317.
33. Elwood JM. Screening for melanoma and options for its evaluation. J Med Screening 1994; 1: 22-38.
34. Sinclair Rod. Start with the KISS principle. [Commentary.] BMJ 1998; 316: 38-39.